TP63 and dermatophytosis: We investigated synergy between ZOL and azole antifungals FLC, ITR, and KET, as they have exhibited synergy in yeast pathogens and are substantially less toxic than other drugs traditionally used to treat dermatophytosis, like terbinafine and griseofulvin.